BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7912220)

  • 1. Polymerase chain reaction-based methods for the detection of mutations in oncogenes and tumor suppressor genes.
    Loda M
    Hum Pathol; 1994 Jun; 25(6):564-71. PubMed ID: 7912220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Techniques in molecular biology.
    Grubb G
    Acta Orthop Scand Suppl; 1997 Feb; 273():74-80. PubMed ID: 9057591
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
    Zhuang S; Söderkvist P
    Mutat Res; 2000 Jul; 452(1):19-26. PubMed ID: 10894886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple genetic lesions in laryngeal squamous cell carcinomas.
    Fracchiolla NS; Pignataro L; Capaccio P; Trecca D; Boletini A; Ottaviani A; Polli E; Maiolo AT; Neri A
    Cancer; 1995 Mar; 75(6):1292-301. PubMed ID: 7882279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oncogenes and tumor-suppressor genes].
    Spatz A
    Arch Anat Cytol Pathol; 1992; 40(2-3):88-94. PubMed ID: 1449269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenes in gynecologic malignancy.
    Baker V
    Curr Opin Obstet Gynecol; 1992 Feb; 4(1):75-80. PubMed ID: 1543833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of oncogenes and anti-oncogenes].
    Thomas G
    Pathol Biol (Paris); 1995 Mar; 43(3):143-9. PubMed ID: 7675540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic multiplex polymerase chain reaction and reverse transcription-polymerase chain reaction analyses of changes in copy number and expression of proto-oncogenes and tumor suppressor genes in cancer tissues and cell lines.
    Yamamoto M; Metoki R; Yamamoto F
    Electrophoresis; 2004 Oct; 25(20):3349-56. PubMed ID: 15490458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of hotspot mutations and polymorphisms using an enhanced PCR-RFLP approach.
    Liu WH; Kaur M; Makrigiorgos GM
    Hum Mutat; 2003 May; 21(5):535-41. PubMed ID: 12673796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic mutation analysis by RFLP/PCR.
    Pourzand C; Cerutti P
    Mutat Res; 1993 Jul; 288(1):113-21. PubMed ID: 7686255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCR-SSCP-HDX analysis of pooled DNA for more rapid detection of germline mutations in large genes. The BRCA1 example.
    Kozłowski P; Sobczak K; Napierała M; Woźniak M; Czarny J; Włodzimierz J; Kryzosiak J
    Nucleic Acids Res; 1996 Mar; 24(6):1177-8. PubMed ID: 8604357
    [No Abstract]   [Full Text] [Related]  

  • 12. Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor gene.
    Cybulski C; Krzystolik K; Maher ER; Richard S; Kurzawski G; Gronwald J; Lubiński J
    Hum Genet; 1999 Oct; 105(4):333-6. PubMed ID: 10543401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors.
    Lothe RA; Fossli T; Danielsen HE; Stenwig AE; Nesland JM; Gallie B; Børresen AL
    J Natl Cancer Inst; 1992 Jul; 84(14):1100-8. PubMed ID: 1619684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cloning tumor-related genes and tumor suppressor genes in glioma with polymerase chain reaction-based subtractive hybridization].
    Deng YC; Wang JC; Liu XP; Ji SP; Yao LB
    Ai Zheng; 2005 Jun; 24(6):680-4. PubMed ID: 15946478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated detection of prevalent mutations in BRCA1 and BRCA2 genes, using a fluorogenic PCR allelic discrimination assay.
    Abbaszadegan MR; Struewing JP; Brown KM; Snider JV; Goodsaid F; Gore-Langton R; Hughes MR
    Genet Test; 1997-1998; 1(3):171-80. PubMed ID: 10464643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in human breast cancer cells: dominantly-acting oncogenes and tumor suppressor genes suggest strategies for targeted interference.
    Groner B; Hynes NE
    Int J Cancer Suppl; 1990; 5():40-6. PubMed ID: 2258264
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of bcl-2 oncogene rearrangement in follicular lymphoma: nucleic acid hybridization and polymerase chain reaction compared.
    Crisan D; Anstett MJ; Matta N; Farkas DH
    Clin Chem; 1993 Sep; 39(9):1980-2. PubMed ID: 8375085
    [No Abstract]   [Full Text] [Related]  

  • 19. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X; Porter AT; Honn KV
    Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the P53 tumour suppressor gene in primary lung cancer in Japan.
    Kondo K; Umemoto A; Akimoto S; Uyama T; Hayashi K; Ohnishi Y; Monden Y
    Biochem Biophys Res Commun; 1992 Mar; 183(3):1139-46. PubMed ID: 1348931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.